This cancer drug stock could double as its treatment hits the market, JPMorgan says
- Posted on August 18, 2026
- By CNBC
- 0 Views
- 1 min read
In brief
Generating AI summary…
This cancer drug stock could double as its treatment hits the market, JPMorgan says
The investment bank initiated coverage with an overweight rating.